{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:59:12Z","timestamp":1787497152912,"version":"build-2736575974"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl. 5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Early identification of persons with chronic HBV infection enables infected persons to receive necessary care to prevent or delay onset of liver disease, and enables the identification and vaccination of susceptible household contacts and sex partners, interrupting ongoing transmission. Testing has been recommended previously to enable primary prevention of HBV infection among close contacts for pregnant women, household contacts and sex partners of HBV-infected persons, persons born in countries with hepatitis B surface antigen (HBsAg) prevalence of more than 8%, persons who are the source of blood or body fluid exposures that might warrant postexposure prophylaxis (e.g., needlestick injury to a healthcare worker or sexual assault), and to enable appropriate treatment for infants born to HBsAg-positive mothers and persons infected with human immunodeficiency virus. Recently, with the increasing availability of efficacious hepatitis B treatment, the Centers for Disease Control and Prevention published new recommendations for public health evaluation and management for chronically infected persons and their contacts and extended testing recommendations to include persons born in geographic regions with HBsAg prevalence of greater than 2%, men who have sex with men, and injection drug users. Patient and provider education, developing partnerships between health departments and community organizations, and other resources will be needed to assure appropriate populations are tested and care provided for persons newly identified as HBsAg-positive. (Hepatology 2009;49:S35\u2013S44.)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22882","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T08:29:11Z","timestamp":1278318551000},"page":"S35-S44","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":125,"title":["Recommendations for identification and public health management of persons with chronic hepatitis B virus infection #"],"prefix":"10.1097","volume":"49","author":[{"given":"Cindy M.","family":"Weinbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20241201","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact.","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R6-6-20241201","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A new antigen in leukemia sera.","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"R7-6-20241201","first-page":"46","article-title":"Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.","volume":"112","author":"Perry","year":"1975","journal-title":"Can Med Assoc J"},{"key":"R8-6-20241201","first-page":"43","article-title":"Prevalence and significance of hepatitis B surface antigen in a general hospital.","volume":"112","author":"Feinman","year":"1975","journal-title":"Can Med Assoc J"},{"key":"R9-6-20241201","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.aje.a112088","article-title":"Hippie hepatitis: an epidemiologic investigation conducted within a population of streetpeople.","volume":"101","author":"Saslow","year":"1975","journal-title":"Am J Epidemiol"},{"key":"R10-6-20241201","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a112298","article-title":"Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.","volume":"104","author":"Szmuness","year":"1976","journal-title":"Am J Epidemiol"},{"key":"R11-6-20241201","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-77-5-691","article-title":"Posttransfusion hepatitis after exclusion of commercial and hepatitisB antigenpositive donors.","volume":"77","author":"Alter","year":"1972","journal-title":"Ann Intern Med"},{"issue":"RR5","key":"R13-6-20241201","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients.","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"issue":"RR13","key":"R14-6-20241201","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"issue":"RR16","key":"R15-6-20241201","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents.","volume":"54","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR2","key":"R16-6-20241201","first-page":"1","article-title":"Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"39","year":"1990","journal-title":"MMWR Recomm Rep"},{"key":"R17-6-20241201","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/423390","article-title":"Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"39","author":"Aberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R18-6-20241201","first-page":"1","article-title":"Surveillance for acute viral hepatitis-United States, 2006.","volume":"57","author":"Wasley","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"R19-6-20241201","first-page":"1015","article-title":"Acute hepatitis B among children and adolescents-United States, 1990-2002.","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-6-20241201","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"issue":"Suppl 3","key":"R22-6-20241201","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1086\/533414","article-title":"Management of hepatic complications in HIVinfected persons.","volume":"197","author":"Sulkowski","year":"2008","journal-title":"J Infect Dis"},{"key":"R26-6-20241201","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.trstmh.2005.12.003","article-title":"Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia.","volume":"101","author":"Madani","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 1","key":"R27-6-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2007.00924.x","article-title":"Hepatitis A and B vaccination and public health.","volume":"14","author":"Hollinger","year":"2007","journal-title":"J Viral Hepat"},{"key":"R28-6-20241201","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination.","volume":"28","author":"Shepard","year":"2006","journal-title":"Epidemiol Rev"},{"key":"R29-6-20241201","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1016\/S0264-410X(01)00120-7","article-title":"The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5yearolds.","volume":"19","author":"Tsebe","year":"2001","journal-title":"Vaccine"},{"key":"R30-6-20241201","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/cncr.22642","article-title":"The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.","volume":"109","author":"Chang","year":"2007","journal-title":"Cancer"},{"key":"R32-6-20241201","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(08)60181-6","article-title":"Curbing the liver cancer epidemic in Africa.","volume":"371","author":"Hainaut","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 2","key":"R33-6-20241201","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1136\/gut.38.Suppl_2.S56","article-title":"Epidemiology of hepatitis B virus infection in India.","volume":"38","author":"Tandon","year":"1996","journal-title":"Gut"},{"key":"R34-6-20241201","first-page":"317","article-title":"Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine.","volume":"31","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R35-6-20241201","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.89.2.269","article-title":"Horizontal transmission of hepatitis B virus infection to United Statesborn children of Hmong refugees.","volume":"89","author":"Hurie","year":"1992","journal-title":"Pediatrics"},{"key":"R36-6-20241201","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.96.6.1113","article-title":"Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.","volume":"96","author":"Mahoney","year":"1995","journal-title":"Pediatrics"},{"key":"R37-6-20241201","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM198911093211905","article-title":"Hepatitis B infection among children born in the United States to southeast Asian refugees.","volume":"321","author":"Franks","year":"1989","journal-title":"N Engl J Med"},{"key":"R39-6-20241201","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(74)91756-5","article-title":"Role of hepatitisB antigen carriers in nonparenteral transmission of the hepatitisB virus.","volume":"2","author":"Heathcote","year":"1974","journal-title":"Lancet"},{"key":"R40-6-20241201","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.aje.a113406","article-title":"Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection.","volume":"116","author":"Bernier","year":"1982","journal-title":"Am J Epidemiol"},{"key":"R41-6-20241201","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.1974.03230220032011","article-title":"Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers.","volume":"227","author":"Irwin","year":"1974","journal-title":"JAMA"},{"key":"R42-6-20241201","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.puhe.2004.09.007","article-title":"Hepatitis B infection in Eastern Indian families: need for screening of adult siblings and mothers of adult index cases.","volume":"119","author":"Chakravarty","year":"2005","journal-title":"Public Health"},{"key":"R43-6-20241201","first-page":"158","article-title":"HIV and hepatitis B infection and risk behavior in young gay and bisexual men.","volume":"112","author":"Seage","year":"1997","journal-title":"Public Health Rep"},{"key":"R44-6-20241201","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2105\/AJPH.91.6.965","article-title":"Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men.","volume":"91","author":"MacKellar","year":"2001","journal-title":"Am J Public Health"},{"key":"R45-6-20241201","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2105\/AJPH.2006.101915","article-title":"The Young Mens Survey Phase II: hepatitis B immunization and infection among young men who have sex with men.","volume":"98","author":"Weinbaum","year":"2008","journal-title":"Am J Public Health"},{"key":"R46-6-20241201","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1001\/jama.1977.03280250051022","article-title":"Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men.","volume":"238","author":"Dietzman","year":"1977","journal-title":"JAMA"},{"key":"R47-6-20241201","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/146.1.7","article-title":"Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.","volume":"146","author":"Schreeder","year":"1982","journal-title":"J Infect Dis"},{"key":"R48-6-20241201","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-83-4-489","article-title":"On the role of sexual behavior in the spread of hepatitis B infection.","volume":"83","author":"Szmuness","year":"1975","journal-title":"Ann Intern Med"},{"key":"R49-6-20241201","first-page":"589","article-title":"Prevalence of HIV and hepatitis B and selfreported injection risk behavior during detention among streetrecruited injection drug users in Los Angeles County, 19941996.","volume":"96","author":"LopezZetina","year":"2001","journal-title":"Addiction"},{"key":"R50-6-20241201","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0002-9343(86)90542-5","article-title":"Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine.","volume":"81","author":"Kunches","year":"1986","journal-title":"Am J Med"},{"key":"R51-6-20241201","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(82)90976-X","article-title":"Multicentre study of prevalence of HBVassociated delta infection and liver disease in drugaddicts.","volume":"1","author":"Raimondo","year":"1982","journal-title":"Lancet"},{"key":"R52-6-20241201","first-page":"30","article-title":"Seroepidemiology of viral infections among intravenous drug users in northern California.","volume":"156","author":"Zeldis","year":"1992","journal-title":"West J Med"},{"key":"R53-6-20241201","first-page":"121","article-title":"Liver tests, HBAg and HBAb in asymptomatic drug addicts.","volume":"65","author":"Mangla","year":"1976","journal-title":"Am J Gastroenterol"},{"key":"R54-6-20241201","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000441-197507000-00006","article-title":"Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study.","volume":"270","author":"Seeff","year":"1975","journal-title":"Am J Med Sci"},{"key":"R55-6-20241201","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000441-197611000-00001","article-title":"The natural history of liver disease in former drug users.","volume":"272","author":"Cherubin","year":"1976","journal-title":"Am J Med Sci"},{"key":"R56-6-20241201","first-page":"164","article-title":"Hepatitis B antigen and antibody in heroin users.","volume":"71","author":"Blanck","year":"1979","journal-title":"Am J Gastroenterol"},{"key":"R57-6-20241201","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virusinfected subjects.","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"R58-6-20241201","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/003335490612100108","article-title":"Surveillance programs for chronic viral hepatitis in three health departments.","volume":"121","author":"Fleming","year":"2006","journal-title":"Public Health Rep"},{"key":"R59-6-20241201","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/jurban\/jti094","article-title":"Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.","volume":"82","author":"Bialek","year":"2005","journal-title":"J Urban Health"},{"key":"R60-6-20241201","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses.","volume":"149","author":"Hagan","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R61-6-20241201","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV1, hepatitis B virus, and risk of liverrelated mortality in the Multicenter Cohort Study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 3","key":"R62-6-20241201","doi-asserted-by":"crossref","first-page":"H3","DOI":"10.1177\/135965350701203S02","article-title":"The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.","volume":"12","author":"McGovern","year":"2007","journal-title":"Antivir Ther"},{"key":"R64-6-20241201","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/00002030-200410210-00008","article-title":"Survival in patients with HIV infection and viral hepatitis B or C: a cohort study.","volume":"18","author":"Bonacini","year":"2004","journal-title":"AIDS"},{"key":"R65-6-20241201","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/infdis\/163.3.454","article-title":"Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.","volume":"163","author":"Hadler","year":"1991","journal-title":"J Infect Dis"},{"key":"R66-6-20241201","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"key":"R67-6-20241201","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.21783","article-title":"Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.","volume":"46","author":"Saab","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R68-6-20241201","first-page":"505","article-title":"Screening for chronic hepatitis B among AsianPacific Islander populationsNew York City, 2005.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R69-6-20241201","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10903-006-9322-1","article-title":"Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men.","volume":"8","author":"Choe","year":"2006","journal-title":"J Immigr Minor Health"},{"key":"R70-6-20241201","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1015229405765","article-title":"Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington.","volume":"27","author":"Taylor","year":"2002","journal-title":"J Community Health"},{"key":"R71-6-20241201","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.21784","article-title":"Why we should routinely screen Asian American adults for hepatitis B: a crosssectional study of Asians in California.","volume":"46","author":"Lin","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R72-6-20241201","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B: AASLD practice guidelines.","volume":"45","author":"Lok","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R73-6-20241201","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1478-3231.2005.01134.x","article-title":"AsianPacific consensus statement on the management of chronic hepatitis B: a 2005 update.","volume":"25","author":"Liaw","year":"2005","journal-title":"Liver Int"},{"key":"R74-6-20241201","first-page":"533","article-title":"EASL International Consensus Conference on Hepatitis B. 1314 September, 2002: Geneva, Switzerland. Consensus statement (short version).","volume":"38","year":"2003","journal-title":"J Hepatol"},{"key":"R75-6-20241201","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R77-6-20241201","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/1097-0142(19820215)49:4<672::AID-CNCR2820490415>3.0.CO;2-#","article-title":"The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage.","volume":"49","author":"Ohnishi","year":"1982","journal-title":"Cancer"},{"key":"R78-6-20241201","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0168-8278(98)80339-5","article-title":"Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients.","volume":"28","author":"Ikeda","year":"1998","journal-title":"J Hepatol"},{"key":"R80-6-20241201","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-147-7-200710020-00004","article-title":"Costeffectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.","volume":"147","author":"Hutton","year":"2007","journal-title":"Ann Intern Med"},{"key":"R81-6-20241201","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States-an analysis of costeffectiveness.","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med"},{"key":"R82-6-20241201","first-page":"271","article-title":"Screening for diabetes mellitus in highrisk patients: cost, yield, and acceptability.","volume":"4","author":"OConnor","year":"2001","journal-title":"Eff Clin Pract"},{"issue":"5","key":"R83-6-20241201","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1542\/peds.110.5.855","article-title":"Projected costeffectiveness of statewide universal newborn hearing screening.","volume":"110","author":"Keren","year":"2002","journal-title":"Pediatrics"},{"key":"R85-6-20241201","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.AOG.0000263470.89007.e3","article-title":"First and secondtrimester evaluation of risk for Down syndrome.","volume":"110","author":"Ball","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"RR8","key":"R86-6-20241201","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22882","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:10:36Z","timestamp":1733040636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":71,"journal-issue":{"issue":"Suppl. 5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22882","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}